Connect with us

Politics

Ben Jealous Talks Marijuana, Dave Chappelle And His Campaign For Maryland Governor

Published

on

Ben Jealous is serious about legalizing marijuana in Maryland if he wins the state’s gubernatorial election in November. And with early polls showing him in the lead as the June 26 Democratic primary approaches, the former NAACP president might just get his shot.

For Jealous, a progressive candidate endorsed by Sens. Bernie Sanders (I-VT) and Kamala Harris (D-CA), among others, his stance on cannabis policy has evolved over time—but he’s put full legalization front and center during his gubernatorial campaign.

Marijuana Moment reached Jealous by phone to learn more about his plans for marijuana reform if elected governor.

This interview has been lightly edited for length and clarity.

Marijuana Moment: You tweeted recently that comedian Dave Chappelle was the first person to tell you that cannabis should be legal. Can you describe that conversation and how it influenced your own personal views? 

Ben Jealous: We were young and we were 20 years old in Mississippi. And Dave had come down there. I was organizing to stop a governor from turning a black college into a prison, and I was stressed out because Dave wanted to fire up a joint, and I didn’t want to go to jail in Mississippi. Dave was like ‘well, this shit should be legal,’ and I was like, ‘yeah, but it’s not.’ That was basically the conversation.

And then it was just an ongoing conversation about the history of marijuana enforcement—the way it was targeted at our community and Latino communities, and that just sort of opened my eyes. And that led me as president of the NAACP pushing for decriminalization in a number of states and cities. That’s ultimately where that conversation led. Dave was the one who really first talked to me about the way in which marijuana enforcement had been targeted at our communities. It just so happened that that day in Mississippi, the stakes were so high, I wasn’t really having it.

MM: Let’s talk more about the evolution of your position on cannabis reform. Were there any other major factors that led you to adopt a pro-legalization stance? 

BJ: I did not start the campaign thinking that this was going to be one of the big issues that I was going to be talking about. However, I did start the campaign knowing that we were going to have to deal head on with the violence in Baltimore and the shootings elsewhere around the state, including places like Prince George’s County. And so around the second anniversary of the uprisings in Baltimore, I asked a retired member of the Baltimore Police Department to go talk to commanders that he knew across the city and just ask them, ‘why are the shootings surging? What’s going on with the violence?’

And he came back and he said, ‘Ben, you know, there were two big data points.’ I said, ‘OK, what are they?’ He said, ‘one, nobody can really agree why the shootings have been surging in recent years. However, everybody is in agreement that approximately half of the shootings in the past 10 years had been one set of marijuana dealers killing another set of marijuana dealers.’ That made me sit up straight, because it really laid bare that we could be saving lives if we legalized cannabis. And that added to the mountains of evidence of the good that could be done to advance racial justice, the good that could be done to increase revenues for universal pre-k.

MM: It’s estimated that full legalization would bring in upwards of $120 million in tax revenue for Maryland. What’s your top priority in terms of how you’d like to see that revenue allocated?

BJ: One of the things that excites me, as I look forward to the day when we legalize cannabis in Maryland, is that we know that when we do, we will be able to decrease the shootings in Baltimore and throughout the state, and we’ll be able to increase five-year-olds’ readiness to start kindergarten. It’s a great win-win. And it’s rare in politics, but it’s also urgently needed. We know that we have to end mass incarceration—and yet go further. We have to really get back to opening up the gates of opportunity for all of our children. And by legalizing cannabis, we get to make progress on both fronts.

We’ll be able to decrease the number of people going into prisons, we’ll be able to make our streets safer and cut the violence on our streets significantly, but we’ll also be able to generate tax revenues that will cover the costs of providing universal pre-k for every child in the state. And that itself will strike a blow against mass incarceration because we know that the better prepared a child is for kindergarten, the more likely they are to do well in school and stay in school and end up in a good job. It’s a true win-win.

MM: What would your message to Democratic presidential candidates in 2020 be when it comes to the issue of legalization?

BJ: Speaking as a Democrat, as party that is committed to being the party of working people, the party of economic justice, the party of racial justice, the party of civil rights, it should be an easy decision at this point. States like Colorado and Washington, D.C and Washington State have led the way, shown that it decreases violence, and it increases tax revenues, while taking the money out of the pockets of gangs and cartels that are engaged in a lot of other very dangerous criminal activities. It’s just common sense—and courage and common sense should be the hallmarks of the Democratic party.

MM: Can you speak to the importance of strengthening the state’s diversity requirements for marijuana licenses?

BJ: Let us never forget that this is the 21st century. Our Republican governor rolled out the new medical cannabis as if it were the 19th century. In a state that’s 53 percent women and 48.5 percent people of color, 100 percent of the licenses went to white-owned companies and virtually none went to women. That should never be allowed to happen again. When I’m governor, we will go further. We will make sure that the ownership is inclusive, but we’ll also make sure that people from the neighborhoods that have been adversely affected by the war on drugs are included in both ownership and employment. The illegal cannabis trade has been a steady employer in a lot of very poor neighborhoods like Upton, where my mom grew up in West Baltimore. We must build this industry in a way that lifts up the people from the places that have paid the steepest price in the war on drugs.

These States Will Probably Vote On Marijuana In 2018

Photo courtesy of Gage Skidmore.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Politics

Feds Award $3 Million In Grants To Study Marijuana Ingredients As Alternatives To Opioids

Published

on

The federal government has awarded $3 million in grants for research into the therapeutic benefits of ingredients in marijuana other than THC, emphasizing their potential as alternatives to prescription opioids.

In a notice published on Thursday, the National Institutes of Health (NIH) explained why the studies were necessary and listed grant recipients and the subjects they will investigate. That includes research into the use of CBD for arthritis pain, which will be led by New York University School of Medicine.

“The treatment of chronic pain has relied heavily on opioids, despite their potential for addiction and overdose and the fact that they often don’t work well when used on a long-term basis,” Helene Langevin, director of the National Center for Complementary and Integrative Health (NCCIH), said in a press release. “There’s an urgent need for more effective and safer options.”

A total of nine grants were issued, with NIH stating that the funds will help identify alternative treatment options for pain and provide information about the impact of consuming cannabis compounds such as CBD and other lesser-known cannabinoids as well as terpenes found in the plant.

“The cannabis plant contains more than 110 cannabinoids and 120 terpenes, but the only compound that’s been studied extensively is THC,” the press release said.

But while THC is known to treat certain forms of pain, NIH is concerned that its intoxicating effects limit its medical applicability.

“THC may help relieve pain, but its value as an analgesic is limited by its psychoactive effects and abuse potential,” David Shurtleff, deputy director of NCCIH, said. “These new projects will investigate substances from cannabis that don’t have THC’s disadvantages, looking at their basic biological activity and their potential mechanisms of action as pain relievers.”

NIH first announced that it would be issuing grants for studies into minor cannabinoids and terpenes last year.

Federal health agencies aren’t the only institutions interested in learning about marijuana compounds other than THC. On Wednesday, a Senate committee issued a spending report that called for research into CBD and CBG while also criticizing the federal drug scheduling system for inhibiting such research.

Read descriptions of the federal cannabinoid and terpene research grant awards below:

Mechanism and Optimization of CBD-Mediated Analgesic Effects; Boston Children’s Hospital, Boston,; Zhigang He, Ph.D., B.M., and Juan Hong Wang, Ph.D. This project will investigate how the pain-relieving effects of cannabidiol (CBD) and other minor cannabinoids may be modulated by the activity of potassium-chloride cotransporter 2 (KCC2), a chloride extruder expressed in most neurons. (Grant 1R01AT010779)

Neuroimmune Mechanisms of Minor Cannabinoids in Inflammatory and Neuropathic Pain; University of California, San Francisco; Judith Hellman, M.D., and Mark A. Schumacher, M.D., Ph.D. This project will explore the effects of minor cannabinoids on inflammatory and neuropathic pain in vitro and in vivo, focusing on the interactions of the cannabinoids with the peripheral receptor called TRPV1 and a cannabinoid receptor, CB1R. (Grant 1R01AT010757)

Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics; Research Triangle Institute, Research Triangle Park, North Carolina; Jenny L. Wiley, Ph.D. This project will evaluate purified biosynthesized minor cannabinoids and selected terpenes alone and in planned combinations to determine their potential efficacy as pain relievers against acute thermal, inflammatory, neuropathic, and visceral pain. (Grant 1R01AT010773)

Identifying the Mechanisms of Action for CBD on Chronic Arthritis Pain; New York University School of Medicine, New York City; Yu-Shin Ding, Ph.D. This project will use neuroimaging studies and behavioral assessments to investigate the mechanisms of action of CBD in the modulation of chronic pain associated with osteoarthritis in a mouse model. (Grant 1R21AT010771)

Synthetic Biology for the Chemogenetic Manipulation of Pain Pathways; University of Texas, Austin; Andrew Ellington, Ph.D. This project will use a novel method to evolve individual variants of cannabinoid receptor type 2 (CB2) that interact with high affinity with minor cannabinoids and evaluate the new variants in a mouse model of pain. (Grant 1R21AT010777)

Exploring the Mechanisms Underlying the Analgesic Effect of Cannabidiol Using Proton Magnetic Resonance Spectroscopy; University of Utah, Salt Lake City; Deborah A. Yurgelun-Todd, Ph.D. This project will use proton magnetic resonance spectroscopy (1H-MRS) to evaluate changes in brain chemistry in critical pain-processing regions after short-term administration of a cannabis extract enriched in CBD. (Grant 1R21AT010736)

Mechanistic Studies of Analgesic Effects of Terpene Enriched Extracts from Hops; Emory University, Atlanta; Cassandra L. Quave, Ph.D. This project will take a multidisciplinary approach to investigate the analgesic effects of terpenes from Humulus lupulus (hops), a plant that is closely related to cannabis and has a very similar terpene profile. (Grant 1R21AT010774)

Systematic Investigation of Rare Cannabinoids With Pain Receptors; University of Illinois at Urbana-Champaign; David Sarlah, Ph.D. This project involves synthesizing several classes of rare phytocannabinoids, systematically evaluating their anti-inflammatory potential, and examining the effects of the compounds with the strongest anti-inflammatory potential on the major receptors involved in pain sensation. (Grant 1R21AT010761)

Analgesic efficacy of single and combined minor cannabinoids and terpenes; Temple University, Philadelphia; Sara J. Ward, Ph.D. This project will use rodent models of pain to evaluate the effects of four biologically active components of cannabis that may act synergistically to protect against pain development and to assess the interactions of these four substances with morphine. (Grant 1R01AT010778)

Senate Report Slams Drug Scheduling System For Blocking Marijuana Research

 

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Beto O’Rourke Proposes Drug War Reparations Funded By Marijuana Taxes

Published

on

Marijuana would not only be legalized under a plan proposed on Thursday by Democratic presidential candidate Beto O’Rourke, but cannabis tax revenue would be used to directly repay formerly incarcerated people through a new “Drug War Justice Grant” program.

Unlike other contenders who have come around to supporting marijuana legalization in just the past couple of years, the former Texas congressman has long called for ending prohibition—and his new plan in many respects goes further than those rolled out by other campaigns.

Please visit Forbes to read the rest of this piece.

(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Support Grows For Marijuana Legalization Bill In Colombia

Published

on

Colombia’s legislature will soon take up a bill to legalize and regulate the production and consumption of marijuana for adults.

The legislation, which is being filed by Sen. Gustavo Bolivar of the opposition Colombia Humana party, seeks to end prohibition as a means of curtailing crime and supporting a public health-focused approach to drug policy.

Bolivar, an author who has written several books centered on drug trafficking, has characterized the bill as being about “regularization, not legalization,” but it would provide for legal sales to adults with restrictions similar to those imposed for tobacco and alcohol. There would be penalties for selling to underage individuals and smoking wouldn’t be permitted in public spaces.

The senator pointed to Uruguay, Canada and states in the U.S. as regulatory models for legalization.

“It has been proven that crime levels are lowered and public health is improved,” he said, according to Colombia Reports.

Sen. Alberto Castilla Salazar of the leftist Polo Democrático party said that his coalition supports the reform measure.

“Colombia must overcome prohibitionism and break the ties of illegal groups with the control of cannabis, so that it is the State that regulates, defines the forms and understands consumption as a public health problem,” he said on Tuesday.

Sen. Julián Gallo Cubillos of the FARC party said his coalition supports the legislation and that it represents “a new way to fight the scourge of drug trafficking.”

The proposal has also garnered the support of former President Juan Manuel Santos, who has been an outspoken advocate for ending the war on drugs. His Liberal party could make or break the legislation depending on where members fall.

While left and center-left lawmakers seem largely united around legalizing marijuana, the issue will likely face resistance from President Ivan Duque, who last year signed a decree banning low-level possession of cannabis and cocaine despite court rulings that such activity is permissible.

As Colombia Reports noted, however, Duque’s far-right Democratic Center party is in the minority.

“We’ll have to see how many senators are left to former president Juan Manuel Santos and see how public opinion receives the idea that marijuana can be consumed in public spaces,” Sen. Paloma Valencia, a member of the president’s party, said.

If the country does opt to pursue a regulated cannabis program, it will join Mexico, where lawmakers are readying legislation to legalize marijuana for adult use following a Supreme Court ruling establishing that a ban on possession and cultivation for personal use is unconstitutional.

Former White House Drug Czar Offers Marijuana Legalization Advice To Mexico

Photo courtesy of Brian Shamblen.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!